On the other hand, most of the selected indicators would not be susceptible to manipulation because they are based on laboratory results such as LDL cholesterol levels or HbA1c levels in patients with diabetes, or prescription data for specific drugs (e.g., antiplatelets, anticoagulants, beta-blockers, angiotensin-converting enzyme inhibitors). This evidence concerns the gene ACE and diabetes mellitus.